New Zealand Continuous Glucose Monitoring Devices Market Share

Statistics for the 2023 & 2024 New Zealand Continuous Glucose Monitoring Devices market share, created by Mordor Intelligence™ Industry Reports. New Zealand Continuous Glucose Monitoring Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of New Zealand Continuous Glucose Monitoring Devices Industry

The New Zealand Continuous Glucose Monitoring Devices Market is highly consolidated, with few significant players. Manufacturers like Abbott, Dexcom, and Medtronic have a global market presence and occupy a major share. There have been constant innovations driven by these manufacturers while also adhering to organic growth strategies, which is evident from the R&D spending of these companies.

New Zealand Continuous Glucose Monitoring Devices Market Leaders

  1. Abbott Diabetes Care

  2. Dexcom, Inc.

  3. Eversense

  4. Medtronic PLC

  5. AiDEX

*Disclaimer: Major Players sorted in no particular order

New Zealand Continuous Glucose Monitoring Devices Market Concentration

New Zealand Continuous Glucose Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)